---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-025893"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T16:42:46.386695+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics annual meeting elects three Class I directors, ratifies KPMG, approves say-on-pay

## Summary
- Yezan Haddadin, Faisal G. Sukhtian, Kurt J. Hilzinger elected as Class I directors with votes for >12M each.
- KPMG LLP ratified as independent auditor for FY2026 with 35.6M votes for, 0.8M against, 0.9M abstain.
- Non-binding advisory vote on exec compensation approved: 13.9M for, 1.5M against, 0.4M abstain.
- Approximately 50.7% of outstanding shares (37.3M of 73.5M) represented at meeting.

## SEC filing metadata
- accession: 0001104659-26-025893
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465926025893/0001104659-26-025893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465926025893/tm268371d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-025893
- JSON: https://secwatch.observer/filing/0001104659-26-025893.json
- Plain text: https://secwatch.observer/filing/0001104659-26-025893.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.